Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Necrosulfonamide
60
CHF
CHF 60.00
In stock
AG-CR1-3705-M0055 mgCHF 60.00
AG-CR1-3705-M02525 mgCHF 240.00
| Product Details | |
|---|---|
| Synonyms | NSA; (2E)-N-[4-[[(3-Methoxy-2-pyrazinyl)amino]sulfonyl]phenyl]-3-(5-nitro-2-thienyl)-2-propenamide |
| Product Type | Chemical |
| Properties | |
| Formula |
C18H15N5O6S2 |
| MW | 461.5 |
| CAS | 1360614-48-7 |
| Purity Chemicals | ≥95% |
| Appearance | Off-white to yellow solid. |
| Solubility | Soluble in DMSO (20mg/ml) or DMF (20mg/ml). Insoluble in water. |
| Identity | Determined by 1H-NMR. |
| InChi Key | FNPPHVLYVGMZMZ-XBXARRHUSA-N |
| Smiles | O=C(/C=C/C1=CC=C([N+]([O-])=O)S1)NC2=CC=C(S(NC3=C(OC)N=CC=N3)(=O)=O)C=C2 |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Keep cool and dry. Protect from light. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Inhibitor of necroptosis, by blocking mixed lineage kinase domain-like protein (MLKL), a key substrate of receptor-interacting serine-threonine kinase 3 (RIP3). Shown to prevent the MLKL-RIP1-RIP3 necrosome complex from interacting with downstream necrosis effectors.
- Potent inhibitor of gasdermin D that works well for mice studies. It binds directly to gasdermin D and inhibits the oligomerization of the N-terminus and therefore the pore formation and pyroptosis.
- Displayed neuroprotective effects after ischemic brain injury, prevented cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells and rescued cells from TLR3 ligand-induced death.
Product References
- Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase: L. Sun, et al.; Cell 148, 213 (2012)
- Necrosulfonamide inhibits necroptosis by selectively targeting the mixed lineage kinase domain-like protein: D. Liao, et al. Med. Chem. Commun. 5, 333 (2014)
- The degradation of mixed linage kinase domain-like protein promotes neuroprotection after ischemic brain injury: Y. Zhou, et al.; Oncotarget 8, 68393 (2017)
- CHAC1 degradation of glutathione enhances cysteine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-elF2α-ATF4 pathway: M.S. Chen, et al.; Oncotarget 8, 114588 (2017)
- Activated platelets induce MLKL-driven neutrophil necroptosis and release of neutrophil extracellular traps in venous thrombosis: D. Nakazawa, et al.; Cell Death Discov. 5, (2018)
- Necrosulfonamide attenuates spinal cord injury via necroptosis inhibition: Y. Wang, et al.; World Neurosurg. 114, e1186 (2018)
- Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis: J.K. Rathkey, et al.; Sci. Immunol. 3, eaat2738 (2018)
- Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation: D. Cuchet-Lourenco, et al.; Science 361, 810 (2018)
- The colonic pathogen Entamoeba histolytica activates caspase-4/1 that cleaves the pore-forming protein gasdermin D to regulate IL-1β secretion: S. Wang, et al.; PLoS Pathog. 18, e1010415 (2022)
Related Products
